The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals

Author： Glennie J.L.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.15, Iss.5, 1999-05, pp. : 459-468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Reappraisal of Economic Evaluation of Pharmaceuticals: Science or Marketing?

By Drummond M.F.  

PharmacoEconomics, Vol. 14, Iss. 1, 1998-07 ,pp. : 1-9

Adis International

Access to resources Recommend Favorite

Documentation of Pediatric Drug Safety in Manufacturers' Product Monographs: A Cross-Sectional Evaluation of the Canadian Compendium of Pharmaceuticals and Specialities

By Uppal Navjeet K.   Dupuis Lee L.   Parshuram Christopher S.  

Pediatric Drugs, Vol. 10, Iss. 3, 2008-01 ,pp. : 193-197

Adis International

Access to resources Recommend Favorite

Canadian guidelines for the management of dyslipidaemia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma

By Pink Joshua  

PharmacoEconomics, Vol. 30, Iss. 5, 2012-05 ,pp. : 413-429

Adis International

Access to resources Recommend Favorite

Vigabatrin: guidelines for paediatric use revised

By  

Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite